To investigate the relationship between TGF-β1 and CAFs in tumor microenvironment, we detected the expression of TGF-β and CAFs maker α-SMA in normal breast tissue and tumor tissues obtained from patients with clinical stage I–IV breast cancer. Here, ACTA1 is linked to breast carcinoma.